
Ame Company For Medical Supplies
Ame Company For Medical Supplies (9527.SR) Cash on Hand — Cash & Short-Term Investments
Cash & cash equivalents plus short-term investments from the balance sheet, YoY change, and net cash vs debt context.
9527.SR · cash on hand · updated Dec 31, 2025
Core cash position
as of Dec 31, 2025Cash on Hand = Cash & Cash Equivalents (CCE) + Short-Term Investments, as reported on the balance sheet (10-K/10-Q). Also referred to as cash reserves or cash position. Not free cash flow.
Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · Reported in SAR
Net cash vs debt
Cash vs Debt · Balance Sheet HealthAme Company For Medical Supplies carries a net debt position of $18.0M. Total debt ($27.8M) exceeds cash on hand ($9.7M). Ame Company For Medical Supplies cash vs debt ratio: 26% cash / 74% debt.
Cash on hand history
Annual cash on hand by year
9527.SR cash & short-term investments historyHealthcare Sector Cash Reserves Comparison
About cash on hand & methodology
Ame Company For Medical Supplies (9527.SR) cash on hand as of December 31, 2025 is $9.7M, comprising $9.7M in cash and cash equivalents (CCE) plus $0 in short-term investments — reported as Ame Company For Medical Supplies cash and short-term investments on the balance sheet (10-K filing). Also referred to as Ame Company For Medical Supplies cash reserves or cash position.
Ame Company For Medical Supplies annual cash on hand history shows decreased -59.8% in 2025: decreased -59.8% in 2025. Ame Company For Medical Supplies cash reserves in 2025 reflect the company's capital allocation strategy.
Ame Company For Medical Supplies carries total debt of $27.8M against cash of $9.7M, resulting in a net debt position of -$18.0M. For the full balance sheet, see the Financials → Balance Sheet tab.
Frequently asked questions
9527.SR cash on hand · 5 questionsAs of December 31, 2025, Ame Company For Medical Supplies (9527.SR) has $9,743,740 in cash on hand — defined as cash and short-term investments on the balance sheet. This includes $9,743,740 in cash and cash equivalents (CCE) plus $0 in short-term investments. Latest quarter (December 31, 2025): $9,743,740. Data sourced from the annual 10-K filing via FMP.
▸ Source: FMP /balance-sheet-statement · US GAAP · Ame Company For Medical Supplies · Ame Company For Medical Supplies SEC 10-K & 10-Q filings · US GAAP · Last updated: December 31, 2025